Caspofungin : An echinocandin antifungal for the treatment of invasive aspergillosis

Caspofungin : An echinocandin antifungal for the treatment of invasive aspergillosis

Caspofungin, the first marketed echinocandin antifungal, has been approved for treatment of invasive aspergillosis in patients refractory to or intolerant of standard antifungal therapy. Caspofungin appears to be a unique alternative in the treatment of serious fungal infections that often respond p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Formulary (Cleveland, Ohio) Ohio), 2001-06, Vol.36 (6), p.427
1. Verfasser: Lomaestro, Ben M
Format: Artikel
Sprache:eng
Schlagworte:
Antifungal agents
Antimicrobial agents
Aspergillosis
Chemotherapy
Drug dosages
Drug therapy
Enzymes
FDA approval
Fungi
Health aspects
Hospitals
Infections
Pharmaceuticals
Pharmacokinetics
Pharmacy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Caspofungin, the first marketed echinocandin antifungal, has been approved for treatment of invasive aspergillosis in patients refractory to or intolerant of standard antifungal therapy. Caspofungin appears to be a unique alternative in the treatment of serious fungal infections that often respond poorly to traditional antifungal therapies.
ISSN:1082-801X
1938-1166